Shruthi Ravimohan

1.6k citations

28 papers · 1.1k indexed · 1 hit paper · h-index 13

Impact in

Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
Epidemiology top 10%
- Pneumocystis jirovecii pneumonia detection and treatment

Papers in

Virology 5
- HIV Research and Treatment 5
Infectious Diseases 13
- Tuberculosis Research and Epidemiology 10
- HIV/AIDS drug development and treatment 3

Co-authors: Drew Weissman Gregory P. Bisson Hardy Kornfeld Adam J. Dupuy Corey M. Carlson David A. Largaespada Lara S. Collier Andrew P. Steenhoff
Journals: Clinical Infectious Diseases (6 papers)Journal of Clinical Oncology (3 papers)Annals of Oncology (2 papers)PLoS ONE (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)
Partner nations: United States Botswana South Africa

In The Last Decade

Shruthi Ravimohan

28 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

Tuberculosis and lung damage: from epidemiology to pathophysiology 2018 · 322 citations

Peers

Countries citing papers authored by Shruthi Ravimohan

Since Specialization

Citations

This map shows the geographic impact of Shruthi Ravimohan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shruthi Ravimohan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shruthi Ravimohan more than expected).

Fields of papers citing papers by Shruthi Ravimohan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shruthi Ravimohan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shruthi Ravimohan. The network helps show where Shruthi Ravimohan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shruthi Ravimohan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shruthi Ravimohan Line = papers co-authored together Shruthi Ravimohan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	785O PIVOT IO 001: First disclosure of efficacy and safety of bempegaldesleukin (BEMPEG) plus nivolumab (NIVO) vs NIVO monotherapy in advanced melanoma (MEL) Annals of Oncology ·Adi Diab, Helen Gogas, Shahneen Sandhu, Georgina V. Long, Paolo A. Ascierto, James Larkin, Mario Sznol, Fábio Franke, T-E. Ciuleanu, (unknown), G Galais, Célèste Lebbé, Friedegund Meier, Brendan D. Curti, 佐藤増雄, Hwai‐I Yang, De Araújo, Shruthi Ravimohan, Mary Tagliaferri, Pavels Patlins	2022	8
2	PIVOT IO 011: A phase 1/2 study of bempegaldesleukin (BEMPEG; NKTR-214) plus nivolumab (NIVO) and tyrosine kinase inhibitor (TKI) versus NIVO and TKI alone in patients (pts) with previously untreated advanced or metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology ·Martin H. Voss, Scott S. Tykodi, Marc‐Oliver Grimm, Hans J. Hammers, Brian I. Rini, Nizar M. Tannir, Anila Qureshi, Vicky Tsipouri, Echuri, Shruthi Ravimohan, Melissa A. Reimers	2022	2
3	882TiP Subcutaneous vs intravenous nivolumab in patients with melanoma following complete resection Annals of Oncology ·Paolo A. Ascierto, Peter G. Mohr, Roxana Dronca, Sam Harris, Melissa Wilson, Rezaei Mahdi, Nationaler Ethikrat, 幸子, Shruthi Ravimohan, Arnold Dyck, Melanie Pe Benito, Maxim N. Usachev	2022	2
4	PIVOT IO 009: A phase 3, randomized study of neoadjuvant and adjuvant nivolumab (NIVO) plus bempegaldesleukin (BEMPEG; NKTR-214) versus NIVO alone versus standard of care (SOC) in patients (pts) with muscle-invasive bladder cancer (MIBC) who are cisplatin (cis)-ineligible. Journal of Clinical Oncology ·Petros Grivas, Michiel Simon Van Der Heijden, Andrea Necchi, Arlene O. Siefker‐Radtke, VERN RUTSALA, Anila Qureshi, Yunus Gökmen, Echuri, Shruthi Ravimohan, Yousef Zakharia	2022	6
5	Single-arm, phase 2 study of regorafenib plus nivolumab in patients with mismatch repair-proficient (pMMR)/microsatellite stable (MSS) colorectal cancer (CRC). Journal of Clinical Oncology ·Marwan Fakih, Kanwal Raghav, David Chang, Johanna C. Bendell, Timothy Larson, Allen Lee Cohn, Diego Alfonso Beltrán, David Cosgrove, Sri Fitri Handayani, Lawrence Garbo, Shruthi Ravimohan, Von Potter, David R. D’Adamo, Neelesh Sharma, Ying A. Wang, Sabine Coppieters, Fitria Istikmah, F. R. Cano, Andrew Scott Paulson	2021	52
6	A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis Clinical Infectious Diseases ·Shruthi Ravimohan, Pholo Maenetje, Sara C. Auld, 美玲三浦, Mandla Mlotshwa, S. Dhastagir, Caroline T. Tiemessen, Goshka Macuga, Robert S. Wallis, Gavin Churchyard, Drew Weissman, Hardy Kornfeld, Gregory P. Bisson	2019	13
7	Tuberculosis and lung damage: from epidemiology to pathophysiology European Respiratory Review ·Shruthi Ravimohan, Hardy Kornfeld, Drew Weissman, Gregory P. Bisson Hit paper breakdown →	2018	322
8	Elevated Pre–Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection Clinical Infectious Diseases ·Shruthi Ravimohan, Charlie Bicknell, C. Zara, Houping Ni, Andrew P. Steenhoff, Robert Gross, Drew Weissman, Gregory P. Bisson	2017	7
9	Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation PLoS ONE ·Christopher Vinnard, Shruthi Ravimohan, Charlie Bicknell, Jotam G. Pasipanodya, Shashikant Srivastava, Chawangwa Modongo, Nicola M. Zetola, Drew Weissman, Tawanda Gumbo, Gregory P. Bisson	2017	11
10	Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy EBioMedicine ·Shruthi Ravimohan, Charlie Bicknell, M. Colonna, C. Zara, Andrew P. Steenhoff, Robert Gross, Drew Weissman, Gregory P. Bisson	2015	32
11	Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4⁺T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Clinical Infectious Diseases ·Shruthi Ravimohan, Charlie Bicknell, C. Zara, Andrew P. Steenhoff, F B LEVAGOOD, Ian Frank, Rob Roy MacGregor, Robert Gross, Drew Weissman, Gregory P. Bisson	2015	31
12	Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study The Lancet Infectious Diseases ·Shruthi Ravimohan, Charlie Bicknell, Andrew P. Steenhoff, F B LEVAGOOD, C. Zara, Scarlett L. Bellamy, Rob Roy MacGregor, Robert Gross, Drew Weissman, Gregory P. Bisson	2015	62
13	Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis The Journal of Infectious Diseases ·Shruthi Ravimohan, Charlie Bicknell, Andrew P. Steenhoff, F B LEVAGOOD, Vicki Dowdy, C. Zara, Christiana Popović, Ann Tierney, Harold Tsai, Adam Schwartz, Robert Gross, Rob Roy MacGregor, Scarlett L. Bellamy, Ian Frank, Drew Weissman, Gregory P. Bisson	2013	24
14	Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis Clinical Infectious Diseases ·Gregory P. Bisson, Mooketsi Molefi, Scarlett L. Bellamy, Rameshwari Thakur, Andrew P. Steenhoff, Charlie Bicknell, Christiana Popović, John William Klein, Stephen J. Gluckman, Shruthi Ravimohan, Drew Weissman, Pablo Tebas	2013	60
15	Outcomes in HIV-infected adults with tuberculosis at clinics with and without co-located HIV clinics in Botswana The International Journal of Tuberculosis and Lung Disease ·Allan B. Schwartz, Charlie Bicknell, Andrew P. Steenhoff, Harold Tsai, F B LEVAGOOD, T Chadborn, Mary Kestler, Nicola M. Zetola, Shruthi Ravimohan, A Chapanis	2013	5
16	Early Emergence and Selection of a SIV-LTR C/EBP Site Variant in SIV-Infected Macaques That Increases Virus Infectivity PLoS ONE ·Shruthi Ravimohan, Lúcio Gama, Elizabeth L. Engle, M. Christine Zink, Janice E. Clements	2012	7
17	Regulation of SIVmac239 Basal Long Terminal Repeat Activity and Viral Replication in Macrophages Journal of Biological Chemistry ·Shruthi Ravimohan, Lúcio Gama, Sheila A. Barber, Janice E. Clements	2009	11
18	Rare Case of Renal Cell Carcinoma with Double Inferior Vena Cava with Venous Thrombosis Urology ·Santosh Kumar, Denholm-Young, Shruthi Ravimohan, Noemí Cristina Silva de Souza, Arup Kumar Mandal, Shrawan Kumar Singh	2008	13
19	Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse Nature ·Lara S. Collier, Corey M. Carlson, Shruthi Ravimohan, Adam J. Dupuy, David A. Largaespada	2005	315
20	Postoperative pulmonary function in laparoscopic versus open cholecystectomy: prospective, comparative study. PubMed ·Shruthi Ravimohan, Lileswar Kaman, Ravul Jindal, Rajinder Singh, S K Jindal	2005	34

About Shruthi Ravimohan

Shruthi Ravimohan is a scholar working on Virology, Infectious Diseases, Epidemiology, Immunology and Oncology, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (12 papers), Tuberculosis Research and Epidemiology (10 papers), Infectious Diseases and Tuberculosis (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), HIV Research and Treatment (5 papers), Immunotherapy and Immune Responses (3 papers), HIV/AIDS drug development and treatment (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Infectious Diseases (379 citations), Epidemiology (325 citations), Virology (40 citations), Pulmonary and Respiratory Medicine (207 citations) and Drug Discovery (1 citation). Shruthi Ravimohan has collaborated with scholars based in United States, Botswana and South Africa. Frequent co-authors include Drew Weissman, Gregory P. Bisson, Hardy Kornfeld, Adam J. Dupuy, Corey M. Carlson, David A. Largaespada, Lara S. Collier, Andrew P. Steenhoff, Robert Gross and Scarlett L. Bellamy. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Oncology, Annals of Oncology, PLoS ONE and Journal of Antimicrobial Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact